Document is current

Article History

Received: 17 October 2018

Accepted: 19 October 2018

First Online: 15 November 2018

Compliance with ethical standards

:

: FAP reports grants from Roche and Celgene, other from Roche, Celgene, Eisai, AstraZeneca, Pfizer, Pierre Fabre and Novartis, outside the submitted work. RA has nothing to disclose. JAGS reports personal fees from Novartis and Celgene, grants from AstraZeneca, other from Roche, outside the submitted work. LM reports other from Roche, other from AstraZeneca, other from Novartis, other from Tesaro, outside the submitted work. MM has received speaker honoraria and funding for some independent medical education activities from Roche, Novartis, Astra Zeneca, Kern and Merck outside the submitted work. ED has nothing to disclose. SP reports personal fees and non-financial support from Roche, other from Polyphor, non-financial support from Pierre Fabre, outside the submitted work. AP reports personal fees from Nanostring, Roche, Amgen, Novartis, Eli Lilly and Pfizer, and grants from Roche, Novartis and Nanostring, all outside the submitted work. AP is part of the scientific advisory board of Oncolytics Biotech. SS has nothing to disclose. EC reports personal fees and other from Roche, Pfizer, Novartis, MSD, Celgene, Lilly and Pierre Fabre, outside the submitted work.

: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study, no informed consent is required.